Novilla Pharmaceuticals

Novilla Pharmaceuticals, Inc. is focused on developing a new class of localized medicines designed by AI to target specific areas of disease, thereby minimizing systemic side effects and enhancing treatment efficacy. Their mission is to revolutionize pain care and combat the opioid epidemic by providing effective treatments without the risks associ... ated with widespread drug exposure. The company's first drug candidate, NOV-1776, has shown significant improvements in clinical trials, demonstrating a 212% increase in efficacy over standard treatments. With a team of experts in pain therapeutics, chemical thermodynamics, and AI drug development, Novilla aims to create targeted therapies that deliver powerful results precisely where needed.Read More